Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S (MAL019)
This study has been completed.
Study NCT01556945   Information provided by Walter Reed Army Institute of Research (WRAIR)

First Received on March 14, 2012.   Last Updated on March 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria, Falciparum
Additional conditions recognized in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
RTS,S, FMP1
Sponsors listed in this trial
U.S. Army Office of the Surgeon General
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services